Loading
BioLife Solutions
Maker of CryoStor freeze media used in most approved cell therapies, plus evo cold-chain shippers.
Overview
BioLife Solutions, based in Bothell, Washington, and listed as BLFS, makes the CryoStor freeze media used in most approved cell therapies, plus evo cold-chain shippers. It divested its freezer hardware lines in 2024 to focus on biopreservation media and consumables. OnCo links it to cryopreservation and the cell therapy cold chain. Whether a consumables supplier embedded in approved manufacturing processes can be displaced, given the cost of revalidation, is the fair question. The cold chain technology page carries the wider picture.
Connected
2Similar pages
- CompanyCryoport
Shares Cryopreservation and cell-therapy cold chain and the tag supporting.
- TechnologyCell-therapy orchestration and chain-of-identity software
Shares Cryopreservation and cell-therapy cold chain and the tag supporting.
- TechnologyAllogeneic donor and iPSC master cell banks
Shares Cryopreservation and cell-therapy cold chain and the tag supporting.
- TechnologyApheresis and starting-material collection
Shares Cryopreservation and cell-therapy cold chain and the tag supporting.
fronts
technologies
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
biolifesolutions.com · 1
A source that has moved or gone is reported by the weekly link check. /audit/